Diastat and Xiith nerve injury - a phase IV clinical study of FDA data
We study 1,802 people who take Diastat or have Xiith nerve injury. No report of Xiith nerve injury is found in people who take Diastat.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No report is found.
What is Diastat?
Diastat has active ingredients of diazepam. eHealthMe is studying from 1,791 Diastat users for its effectiveness, alternative drugs and more.
What is Xiith Nerve Injury?
Xiith nerve injury is found to be associated with 7 drugs and 6 conditions by eHealthMe.
Do you take Diastat and have Xiith nerve injury?Check whether Xiith nerve injury is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Xiith nerve injury and when was it recovered:
Expand to all the drugs that have ingredients of diazepam:
Alternative drugs to, pros and cons of Diastat:
- Diastat (1,791 reports)
Xiith nerve injury treatments and more:
- Xiith nerve injury (11 reports)
COVID vaccines that are related to Xiith nerve injury:
- Xiith nerve injury in Moderna COVID Vaccine
- Xiith nerve injury in Pfizer BioNTech Covid Vaccine
- Xiith nerve injury in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Xiith nerve injury:
All the conditions that are associated with Xiith nerve injury:
How the study uses the data?
The study uses data from the FDA. It is based on diazepam (the active ingredients of Diastat) and Diastat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cyclophosphamide and Lung Cyst - 4 seconds ago
- Benzonatate and Colecalciferol drug interaction - 6 seconds ago
- Lenalidomide and Escitalopram Oxalate drug interaction - 7 seconds ago
- Zometa and Hepatocellular Damage - 14 seconds ago
- Januvia and Dermatitis Exfoliative Aggravated - 15 seconds ago
- Prevpac and Glyburide drug interaction - 16 seconds ago
- Vicodin Es and Muscle Strain - 28 seconds ago
- Eloxatin and Dizziness Postural - 29 seconds ago
- Escitalopram and Seizure Cluster - 36 seconds ago
- Evening Primrose Oil and Hydramine drug interaction - 39 seconds ago